SV Health Investors

SV Health Investors accounts for 23 tracked companies with verified cap-table data, 23 of which disclose round sizes totalling $3.1B. The median disclosed raise is $95M, and the largest is AdvanCell at $440M, ahead of Bardy Diagnostics ($375M) and Quell Therapeutics ($344M).

The names that recur most often on these portfolio cap tables are SV Health Investors (23 companies), Bain Capital Life Sciences (3 companies), Jeito Capital (3 companies), Omega Funds (3 companies), Johnson & Johnson Innovation (3 companies), Sofinnova Partners (3 companies). By latest disclosed round, the market skews Series B (8), Series A (7), Series C (4), Series D (2).

• Companies tracked: 23
• Disclosed funding total: $3.1B across 23 companies
• Median disclosed raise: $95M
• Largest raise: AdvanCell — $440M
• Stage mix: Series B 8 · Series A 7 · Series C 4 · Series D 2
• Most recent dated round: 2026-03-17

Best funded SV Health Investors companies

1. AdvanCell — $440M (latest: Series D)
2. Bardy Diagnostics — $375M (latest: Series B)
3. Quell Therapeutics — $344M (latest: Series B)
4. Aviceda Therapeutics — $210M (latest: Series C)
5. TRex Bio — $193M (latest: Series B)
6. Artios Pharma — $186M (latest: Series C)
7. Imbria Pharmaceuticals — $144M (latest: Series B)
8. Draig Therapeutics — $140M (latest: Series A)
9. Eyebiotech — $130M (latest: Series A)
10. Pulmocide — $122M (latest: Series C)
11. Mestag Therapeutics — $95M (latest: Seed)
12. Xilio Therapeutics — $95M (latest: Series C)
13. Pionyr Immunotherapeutics — $78M (latest: Series B)
14. Sitryx Therapeutics — $75M (latest: Series B)
15. Rondo Therapeutics — $67M (latest: Series A)

SV Health Investors — related firms and companies (56)

• AdvanCell
• Bardy Diagnostics
• Quell Therapeutics
• Aviceda Therapeutics
• TRex Bio
• Artios Pharma
• Imbria Pharmaceuticals
• Draig Therapeutics
• Investors like Thrive Capital
• Investors like AME Cloud Ventures
• Investors like SOSV
• Xilio Therapeutics
• Investors like Plug and Play
• Investors like Bond
• Perfuze
• Investors like GSR Ventures
• Investors like ARCH Venture Partners
• Investors like Uncork Capital
• Mestag Therapeutics
• Investors like Redpoint
• Investors like Thirdbase Capital
• Zerigo Health
• Investors like Alexandria Venture Investments
• Investors like ACME Capital
• Investors like SV Health Investors
• Pulmocide
• Investors like True Ventures
• Investors like Andreessen Horowitz
• Spectrawave
• Investors like Amino Capital
• Investors like DCM Ventures
• SV Health Investors co-investors 2026
• Eyebiotech
• Investors like Norwest Venture Partners
• Investors like BoxGroup
• Dualitas Therapeutics
• Investors like Ribbit Capital
• Investors like Motivate Venture Capital
• Catamaran Bio
• Investors like Scale Venture Partners
• Investors like Bain Capital
• Investors like Alumni Ventures
• Rondo Therapeutics
• Investors like Altos Ventures
• Investors like Amplify Partners
• CarePredict
• Investors like Service Provider Capital
• Investors like Headline
• Investors like CRV
• Sitryx Therapeutics
• Investors like The Westly Group
• Investors like Capital One Ventures
• CSA Medical
• Investors like Western Technology Investment
• Investors like IVP
• Investors like Spark Capital

SV Health Investors profile · All research reports